文献速递心脑血管急症重症综合管理与镇静镇痛

溶栓后事件评估以确定缺血性卒中患者合适的ICU监测时长

Evaluation of Post-thrombolytic Events to Determine Appropriate ICU Monitoring Duration for Patients with Ischemic Stroke.
PubMed 文献 · Neurocrit Care · 2024-04-08
一句话结论回顾性队列显示溶栓后12小时以上症状性颅内出血、神经功能恶化和需ICU干预很少发生,就诊时血压<140/90 mm Hg、NIHSS<10且未行机械取栓者可能是早期降级监护的最佳候选。

该回顾性队列纳入204例接受全剂量阿替普酶溶栓的成人急性缺血性卒中患者,评估溶栓后0-12小时与12-24小时症状性颅内出血(sICH)、神经功能恶化和需ICU干预的发生率。10例(4.9%)发生sICH,其中7例在溶栓后12小时内;62例在12小时内需ICU干预,12小时后仅4例;24例在12小时内神经功能恶化,12小时后7例。多因素分析确定机械取栓和就诊时血压升高是溶栓后12小时以上需ICU干预的预测因素。作者认为就诊时血压<140/90 mm Hg、NIHSS<10且未行机械取栓的患者可能是早期降级监护的最佳候选,但需更大规模前瞻性研究评估早期转出ICU的安全性、可行性和经济影响。

要点

  • 204例接受全剂量阿替普酶溶栓患者中10例(4.9%)发生sICH,其中7例发生在溶栓后12小时内。
  • 溶栓后12小时内62例需ICU干预,12小时后仅4例;12小时内24例神经功能恶化,12小时后7例。
  • 多因素分析显示机械取栓和就诊时血压升高是溶栓后12小时以上需ICU干预的预测因素。
  • 作者认为就诊时血压<140/90 mm Hg、NIHSS<10且未行机械取栓的患者可能是早期降级监护的最佳候选。

适用人群与场景

  • 18岁及以上接受溶栓治疗的急性缺血性卒中成人患者。
  • 排除转至其他机构、24小时内转为舒适照护或临终关怀、缺乏影像学和NIHSS评分数据的患者。

研究设计与关键结果

  • 回顾性队列研究纳入204例接受全剂量阿替普酶溶栓的成人急性缺血性卒中患者。
  • 主要终点:10例(4.9%)发生sICH,其中7例发生在溶栓后12小时内(0-12小时),其余发生在12-24小时(原文未逐一列出12-24小时例数)。
  • 次要终点:62例在溶栓后12小时内需ICU干预,12小时后仅4例;24例在12小时内神经功能恶化,12小时后7例。
  • 多因素分析确定机械取栓和就诊时血压升高是溶栓后12小时以上需ICU干预的预测因素。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为就诊时血压<140/90 mm Hg、NIHSS评分<10且未行机械取栓的患者可能是早期降级监护的最佳候选。
  • 作者指出需要更大规模的前瞻性研究来更全面评估早期转出ICU的安全性、可行性和经济影响。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Standard treatment for eligible patients presenting with acute ischemic stroke (AIS) is thrombolysis with tissue plasminogen activators alteplase or tenecteplase. Current guidelines recommend monitoring patients in an intensive care unit (ICU) for 24 h after thrombolytic therapy. However, recent studies have questioned the need for prolonged ICU monitoring. This retrospective cohort study aims to identify potential candidates for early transition to a lower level of care by assessing risk factors for neurological deterioration, symptomatic intracranial hemorrhage (sICH), or need for ICU intervention within 24 h post-thrombolysis.

METHODS: This retrospective cohort study included adult patients 18 years and older with AIS who received thrombolysis. Patients were excluded if they were transferred to another facility, if they were transitioned to comfort care or hospice care within 24 h, or if they lacked imaging and National Institutes of Health Stroke Scale (NIHSS) score data. The primary end point was incidence of sICH between 0-12 and 12-24 h. Secondary end points included the need for ICU intervention and rates of neurological deterioration.

RESULTS: The analysis included 204 patients who received the full dose of alteplase. Among them, ten patients (4.9%) developed sICH, with the majority (n = 7) occurring within 12 h post-thrombolysis. Sixty-two patients required ICU interventions within 12 h compared with four patients after 12 h. Twenty-four patients had neurological deterioration within 12 h, and seven patients had neurological deterioration after 12 h. Multivariable analysis identified mechanical thrombectomy and increased blood pressure at presentation as predictors of ICU need beyond 12 h post-thrombolysis.

CONCLUSIONS: Our study demonstrates that sICH, neurological deterioration, and need for ICU intervention rarely occur beyond 12 h after thrombolytic administration. Patients presenting with blood pressures < 140/90 mm Hg, NIHSS scores < 10, and not undergoing mechanical thrombectomy may be best candidates for early de-escalation. Larger prospective studies are needed to more fully evaluate the safety, feasibility, and financial impact of early transition out of the ICU.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Reimer J, Wang F, Ramiro J, et al. Evaluation of Post-thrombolytic Events to Determine Appropriate ICU Monitoring Duration for Patients with Ischemic Stroke. Neurocrit Care. 2024. PMID: 38589692. doi:10.1007/s12028-024-01979-3

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。